Literature DB >> 31754211

LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk.

Rong Zhong1, Jianbo Tian1, Mingpeng Fu2, Simin Ma2, Li Liu3, Jiaoyuan Li1, Na Shen4, Juntao Ke1, Yang Yang1, Yajie Gong1, Ying Zhu1, Ying Wang5, Jing Gong1, Jiang Chang1, Ping Lei2, Xiang Cheng6, Kun Huang7, Guanxin Shen2, Xiaoping Miao8.   

Abstract

Interpreting disease-causing variants, especially in noncoding regions by genome-wide association studies (GWAS), has become one of the most challenging and demanding tasks. We hypothesized that functional lncRNAs variants in GWAS-identified loci might alter expression level of genes associated with persistent HBV infection and hepatocellular carcinoma (HCC). Integrated bioinformatics approaches were used to prioritize potentially functional variants and a two-stage case-control study (2473 HBV positive HCC patients, 2248 persistent HBV carriers and 2294 spontaneously recovered subjects) was performed to assess the roles of these variants. The rs2844512 G > C variant in LINC01149 was identified to facilitate HBV spontaneous recovery (OR = 0.84, 95% CI = 0.77-0.92) but increase the risk of HCC (OR = 1.21, 95% CI = 1.11-1.32) in combined samples. Subsequent biological assays indicated this variant created a binding site for miR-128-3p and upregulated MICA expression by serving as a miRNA sponge, which might recruit NK-cells to lyse infected cells, but release highly soluble MICA by shedding to induce NK-cells exhaustion and tumor immune evasion. These findings highlight a regulatory circuit between LINC01149 and MICA, mediating by miR-128-3p, and the important role of upregulated MICA in conferring susceptibility to persistent HBV infection and HCC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31754211     DOI: 10.1038/s41388-019-1117-7

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

1.  Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.

Authors:  Vinod Kumar; Naoya Kato; Yuji Urabe; Atsushi Takahashi; Ryosuke Muroyama; Naoya Hosono; Motoyuki Otsuka; Ryosuke Tateishi; Masao Omata; Hidewaki Nakagawa; Kazuhiko Koike; Naoyuki Kamatani; Michiaki Kubo; Yusuke Nakamura; Koichi Matsuda
Journal:  Nat Genet       Date:  2011-04-17       Impact factor: 38.330

Review 2.  Validating, augmenting and refining genome-wide association signals.

Authors:  John P A Ioannidis; Gilles Thomas; Mark J Daly
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

Review 3.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

4.  Principles for the post-GWAS functional characterization of cancer risk loci.

Authors:  Matthew L Freedman; Alvaro N A Monteiro; Simon A Gayther; Gerhard A Coetzee; Angela Risch; Christoph Plass; Graham Casey; Mariella De Biasi; Chris Carlson; David Duggan; Michael James; Pengyuan Liu; Jay W Tichelaar; Haris G Vikis; Ming You; Ian G Mills
Journal:  Nat Genet       Date:  2011-06       Impact factor: 38.330

5.  Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.

Authors:  Lingmin Hu; Xiangjun Zhai; Jibin Liu; Minjie Chu; Shandong Pan; Jie Jiang; Yixin Zhang; Hua Wang; Jianguo Chen; Hongbing Shen; Zhibin Hu
Journal:  Hepatology       Date:  2012-03-16       Impact factor: 17.425

Review 6.  Epidemiology of hepatitis B and C viruses: a global overview.

Authors:  Helen S Te; Donald M Jensen
Journal:  Clin Liver Dis       Date:  2010-02       Impact factor: 6.126

7.  Hepatitis B: the virus and disease.

Authors:  T Jake Liang
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

8.  New loci associated with chronic hepatitis B virus infection in Han Chinese.

Authors:  Zhibin Hu; Yao Liu; Xiangjun Zhai; Juncheng Dai; Guangfu Jin; Li Wang; Liguo Zhu; Yuan Yang; Jibin Liu; Minjie Chu; Juan Wen; Kaipeng Xie; Guoming Du; Qungang Wang; Yuchun Zhou; Minquan Cao; Li Liu; Yisha He; Ying Wang; Gangqiao Zhou; Weihua Jia; Jiachun Lu; Shengping Li; Jianjun Liu; Haitao Yang; Yongyong Shi; Weiping Zhou; Hongbing Shen
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

9.  Fine mapping the MHC region identified four independent variants modifying susceptibility to chronic hepatitis B in Han Chinese.

Authors:  Meng Zhu; Juncheng Dai; Cheng Wang; Yuzhuo Wang; Na Qin; Hongxia Ma; Ci Song; Xiangjun Zhai; Yuan Yang; Jibin Liu; Li Liu; Shengping Li; Jianjun Liu; Haitao Yang; Fengcai Zhu; Yongyong Shi; Hongbing Shen; Guangfu Jin; Weiping Zhou; Zhibin Hu
Journal:  Hum Mol Genet       Date:  2016-01-13       Impact factor: 6.150

Review 10.  Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.

Authors:  V T T Nguyen; M G Law; G J Dore
Journal:  J Viral Hepat       Date:  2009-03-17       Impact factor: 3.728

View more
  4 in total

1.  An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression.

Authors:  Ting Shen; Ting Ni; Jiaxuan Chen; Haitao Chen; Xiaopin Ma; Guangwen Cao; Tianzhi Wu; Haisheng Xie; Bin Zhou; Gang Wei; Hexige Saiyin; Suqin Shen; Peng Yu; Qianyi Xiao; Hui Liu; Yuzheng Gao; Xidai Long; Jianhua Yin; Yanfang Guo; Jiaxue Wu; Gong-Hong Wei; Jinlin Hou; De-Ke Jiang
Journal:  Nat Commun       Date:  2022-03-09       Impact factor: 14.919

Review 2.  Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma.

Authors:  Qikuan He; Pengyi Guo; Zhiyuan Bo; Haitao Yu; Jinhuan Yang; Yi Wang; Gang Chen
Journal:  Cancer Cell Int       Date:  2022-08-09       Impact factor: 6.429

Review 3.  Long noncoding RNAs in hepatitis B virus replication and oncogenesis.

Authors:  Hui-Chun Li; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

4.  A unified framework identifies new links between plasma lipids and diseases from electronic medical records across large-scale cohorts.

Authors:  Yogasudha Veturi; Anastasia Lucas; Yuki Bradford; Daniel Hui; Scott Dudek; Elizabeth Theusch; Anurag Verma; Jason E Miller; Iftikhar Kullo; Hakon Hakonarson; Patrick Sleiman; Daniel Schaid; Charles M Stein; Digna R Velez Edwards; QiPing Feng; Wei-Qi Wei; Marisa W Medina; Ronald M Krauss; Thomas J Hoffmann; Neil Risch; Benjamin F Voight; Daniel J Rader; Marylyn D Ritchie
Journal:  Nat Genet       Date:  2021-06-17       Impact factor: 38.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.